Correction to: Nature Immunology https://doi.org/10.1038/s41590-020-0773-7, published online 17 August 2020.
In the version of this article initially published online, in the section “Lack of cross-reactivity of existing human coronavirus responses for N, ORF3b and ORF8 by LIPS,” the β-human coronavirus (HCoV) OC43 was incorrectly identified as an α-HCoV and the α-HCoVs 229E and NL63 were incorrectly identified as β-HCoVs. In the Methods section “Patients and samples collection,” it was incorrectly stated that plasma samples were collected from 84 patients with COVID-19. A total of 84 plasma samples were collected from 61 patients with COVID-19. The errors have been corrected in the print, PDF and HTML versions of the article.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Hachim, A., Kavian, N., Cohen, C.A. et al. Author Correction: ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection. Nat Immunol 21, 1302 (2020). https://doi.org/10.1038/s41590-020-0788-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-020-0788-0